Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-058913
Filing Date
2014-09-19
Accepted
2014-09-19 19:34:01
Documents
1
Period of Report
2014-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13388
  Complete submission text file 0001209191-14-058913.txt   14684
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Ruegg Curtis (Reporting) CIK: 0001597578 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 141112857